Surgery

Cardiovascular Prevention in High Risk Patients: Evaluating Current Evidence to Improve Outcomes in Managed Care CVD affects approximately 80 million Americans and is responsible for roughly one third of US mortality, with nearly 2400 CVD-associated deaths occurring each day—more than cancer, chronic lower respiratory... Faculty William J. Cardarelli, PharmD Matthew J. Sorrentino, MD, FACC Dan James Fintel, MD Juan J. Rivera, MD Roger S. Blumenthal, MD, FACC, FCCP, FAHA

Activity Details Credit Types: CME, CPE Credit Amount: 1.00 Type: PDF Expires: Jul 1, 2009 Cost: Free E-mail Begin

Effectively Applying Guidelines to Improve Outcomes in Patients with STEMI Over 75 million US adults have cardiovascular disease (CVD), the leading cause of death in the United States. Of those individuals with CVD, approximately 17 million have coronary artery disease (CAD), leading to... Faculty James M. Atkins, MD Christopher P. Cannon, MD

Activity Details Credit Types: CME, CPE Credit Amount: 1.00 Type: Audio Webcast Expires: Jun 4, 2009 Cost: Free E-mail Begin

Understanding the Evidence: The Role of Medication Management and Coronary Intervention in UA/NSTEMI Over 75 million US adults have cardiovascular disease (CVD), the leading cause of death in the United States. Of those individuals with CVD, approximately 17 million have coronary artery disease (CAD), leading to... Faculty C Michael Gibson, MD James M. Atkins, MD

Activity Details Credit Types: CME, CPE Credit Amount: 1.00 Type: Audio Webcast Expires: Jun 2, 2009 Cost: Free E-mail Begin

Optimizing Antiplatelet Therapy in the ACS Patient: The Intersection of Acute Coronary Syndromes and Oral Antiplatelet Therapy This presentation aims to address the central role of platelets in acute coronary syndromes (ACS) and the use of both oral antiplatelet therapy and interventional therapy as cornerstones... Faculty Deepak L. Bhatt, MD, FACC, FAHA

Activity Details Credit Types: CME Credit Amount: 0.50 Type: Video Webcast Expires: Feb 28, 2009 Cost: Free E-mail Begin

Optimizing Antiplatelet Therapy in the ACS Patient: Limitations of Current Antiplatelet Therapy in ACS and PCI and Potential Solutions This presentation aims to focus on current strategies to optimize oral antiplatelet agents in the treatment of ACS and PCI. Topics addressed include current limitations with clopidogrel, variability in response... Faculty Stephen D. Wiviott, MD

Activity Details Credit Types: CME Credit Amount: 0.50 Type: Video Webcast Expires: Feb 28, 2009 Cost: Free E-mail Begin

Optimizing Antiplatelet Therapy in the ACS Patient: Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel This presentation focuses on the results of the TRITON-TIMI 38 trial, which examines the use of the investigational thienopyridine prasugrel compared to clopidogrel in patients with ACS who were undergoing... Faculty Elliott M. Antman, MD, FACC

Activity Details Credit Types: CME Credit Amount: 1.00 Type: Video Webcast Expires: Feb 28, 2009 Cost: Free E-mail Begin